🗣️ We have a new episode out!

Dr. Stefan Irion (Stefan Irion) from BlueRock Therapeutics talks about the company's #ParkinsonsDisease trial, the challenges of genetically manipulating #StemCells , and his journey from physician to scientist!

🎧 Listen now: bit.ly/3ScDJwQ

Great overview of Kendall Square innovation hub via The Boston Globe

bostonglobe.com/video/2022/06/…

Yesterday, CEO Seth Ettenberg spoke on a panel at the #WorldMedicalInnovationForum presented by Mass General Brigham. The panel focused on Global Biotech Epicenters, with a focus on New England.
youtube.com/clip/UgkxWAtnH…

#BlueRockTx #regenerativemedicine #innovation

BlueRock is in Barcelona this week for Alliance for Regenerative Medicine (ARM) Cell & Gene Meeting on the Med!

#regenerativemedicine

It was great to hear from Cynata Therapeutics, Amicus Therapeutics, Sernova, BlueRock Therapeutics, Adaptimmune, @OxfordBiomedica, SparingVision, GENETHON France, SiSaf, VectorY, CTI Clinical Trials, & @BoneTherapeutic. #CGMED22 !

See you at the MassBio #CareerFair 4/13!

Did You Know? The current standard of care for Parkinson’s disease has remained unchanged for more than 60 years. Learn more about BlueRock’s lead focus on Parkinson’s disease: bluerocktx.com/programs/

You can also watch individual clips featuring Rob Frawley, Lead Community Scientist at BioBus; Rob Coloney, Senior Manager, Talent Acquisition at BlueRock Therapeutics; Shazzia Khan, Global Chief of Staff and Chief Talent Officer at @HavasHealthYou

Congrats! Aino Forsti-Smith, Bayer | Pharmaceuticals Europe; Kim Carson, Yaengsaeng Xayavong, Bayer U.S. 🇺🇸; Stephanie Klocke, Lucy Turland, BD; Joanne Golankiewicz, Stephanie Albanese, Biogen; Ainslie Little, BlueRock Therapeutics
ow.ly/VFpS50IiW9b
#HBAWOTY22 #HBAimpact #genderequality

We are proud to see Seth Ettenberg CEO of BlueRock Therapeutics, a Leaps company, take the stage at #BreakthroughInnovationForum . Last year, BlueRock announced its first patient dosed for it's Phase 1 trial for Parkinson's disease. What a huge step for #Leap 5 - Protect Brain and Mind.

Join BlueRock CEO Seth Ettenberg tomorrow as part of Bayer AG's Breakthrough Innovation Forum. We're turning 'What if?' into 'Here's how' #regenerativemedicine #innovation

Stephanie, Scientist II, on #Courage : “You just need to keep looking forward—figure out what needs to be done. Then engage your team—break down the project so the whole team has a piece of the puzzle.”

#BlueRockers #BlueRockTx #Courage #Leadership

#BlueRocker Mark, Scientist I, on #Urgency : “Urgency requires good communication. We can only be as urgent as we are organized, transparent, and communicative. I could run around as much as I want, but it would be for nothing without a shared sense of urgency from the team.”

BlueRock Therapeutics announced today the dose administration for the first patient in Canada in a Phase 1, open-label trial in patients with advanced #Parkinsons . Read the full release: bit.ly/3GUx99P

BlueRock Therapeutics announced the closeout of the first of two cohorts in our ongoing Phase 1, open-label trial of pluripotent stem cell-derived dopaminergic neurons in patients with advanced #parkinsonsdisease . bit.ly/3qW6H8D

Cheers to 5 years of BlueRock! We celebrate our 5th turn around the sun this week, and are super excited for what the next 5 years brings! #BlueRockers

BlueRock Therapeutics Congrats on being named on Comparably's Top 100 list for Best Company Culture in 2021, as rated by your employees. You’re also featured in Business Insider #ComparablyAwards businessinsider.com/small-midsize-…

BlueRock Therapeutics is a Winner of Comparably’s Best Company Culture 2021! Check out our award-winning company culture as rated by our own employees. lnkd.in/gZiWnajs

JOIN US! lnkd.in/djDchmVK

#BlueRockers #BlueRockTx #culture #community #employerofchoice

Poster award prizes at this year’s #MbDsymposium are sponsored by CCRM BlueRock Therapeutics and STEMCELL Technologies. Thanks for your support!

Stem cells hold the potential to create new and innovative treatments and therapies. Join The Globe and Bayer AG on Nov. 30 for a webcast on what stem cell advances mean for health care. #RegenMedWebcast

Sign up: tgam.ca/RegenMed